Resistell AG
PrivateLast Round
Grant
Jan 1, 2024
Total Funding Raised
$19.98M
Company Overview
Resistell AG operates in Healthcare & Life Sciences and is based in Muttenz. Its latest recorded funding round was a Grant round in January 2024.
Resistell AG is a medtech company developing a rapid antibiotic susceptibility testing (AST) platform using nanomotion technology to combat antimicrobial resistance.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotech Equipment, Precision Medicine, Biotechnology
Business Model
B2B
Customer Profile
Hardware Sales, Usage-Based SaaS, Government Contracts
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Resistell AG Comparables
Compare Resistell AG with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| SoundCell B.V. | 92% | |
| PhAST Diagnostics | 88% | |
| Biolumo Sp. z o.o. | 88% |
For institutional investors. Book with your work email.
Resistell AG Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jan 1, 2024 | ||||
| Series B | Dec 19, 2022 | ||||
| Grant | Jul 3, 2020 | ||||
| Series A | Dec 17, 2019 | ||||
| Grant | Jul 1, 2019 | ||||
Seed | Dec 9, 2018 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Resistell AG Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Innovation Council Fund | Grant |
| Launchpad Venture Group | Series B |
| TRUMPF Venture | Series B, Series A |
| Alpana Ventures | Series A |
| Innosuisse | Grant |
| OCCIDENT | Series B, Series A, Seed |
| Zurcher Kantonalbank | Series B, Series A |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 21, 2026
Monthly visitors increased 142% MoM.
- Jan 5, 2026
Monthly visitors increased 125% MoM.
For institutional investors. Book with your work email.
Resistell AG Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Resistell AG's valuation, stock price, and market status.
Is Resistell AG a public or private company?
Resistell AG is a private company.
What is the current stock price of Resistell AG?
Resistell AG is a private company, so its shares have no public market price. Caplight tracks Resistell AG's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Resistell AG worth (valuation)?
Valuation information for Resistell AG is not publicly available.
Can I buy Resistell AG stock?
Resistell AG shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Resistell AG's last funding round?
Resistell AG's most recent funding round was Grant on January 1, 2024.
Who are the main investors in Resistell AG?
Key investors in Resistell AG include OCCIDENT.
Will Resistell AG IPO soon?
No public IPO plans have been announced for Resistell AG.
How can I track Resistell AG secondary market activity?
Caplight tracks bids, offers, and trades in Resistell AG's shares on secondary markets.